Mahdi Garelnabi to Humans
This is a "connection" page, showing publications Mahdi Garelnabi has written about Humans.
Connection Strength
0.354
-
Punch E, Klein J, Diaba-Nuhoho P, Morawietz H, Garelnabi M. Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis. J Am Heart Assoc. 2022 02; 11(3):e023328.
Score: 0.040
-
Bardon KM, Garelnabi M. The impact of altered mechanobiology on aortic valve pathophysiology. Arch Biochem Biophys. 2020 09 30; 691:108463.
Score: 0.035
-
McGrail L, Garelnabi M. Polyphenolic Compounds and Gut Microbiome in Cardiovascular Diseases. Curr Pharm Biotechnol. 2020; 21(7):578-586.
Score: 0.034
-
Ochin CC, Garelnabi M. Berberine Encapsulated PLGA-PEG Nanoparticles Modulate PCSK-9 in HepG2 Cells. Cardiovasc Hematol Disord Drug Targets. 2018; 18(1):61-70.
Score: 0.030
-
Mazhar Z, Hughes A, Garelnabi M. Targeting the Role of Lipoprotein (a) in Stroke. Cardiovasc Hematol Disord Drug Targets. 2017; 17(1):64-72.
Score: 0.028
-
Garelnabi M, Younis A. Paraoxonase-1 enzyme activity assay for clinical samples: validation and correlation studies. Med Sci Monit. 2015 Mar 27; 21:902-8.
Score: 0.025
-
Younis A, Hawkins K, Mahini H, Butler W, Garelnabi M. Serum tumor necrosis factor-?, interleukin-6, monocyte chemotactic protein-1 and paraoxonase-1 profiles in women with endometriosis, PCOS, or unexplained infertility. J Assist Reprod Genet. 2014 Nov; 31(11):1445-51.
Score: 0.024
-
Garelnabi M, Lor K, Jin J, Chai F, Santanam N. The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research. Clin Biochem. 2013 Jan; 46(1-2):12-9.
Score: 0.021
-
Younis A, Clower C, Nelsen D, Butler W, Carvalho A, Hok E, Garelnabi M. The relationship between pregnancy and oxidative stress markers on patients undergoing ovarian stimulations. J Assist Reprod Genet. 2012 Oct; 29(10):1083-9.
Score: 0.020
-
Garelnabi M, Gupta V, Mallika V, Bhattacharjee J. Platelets oxidative stress in Indian patients with ischemic heart disease. J Clin Lab Anal. 2010; 24(1):49-54.
Score: 0.017
-
Garelnabi M, Veledar E, Abramson J, White-Welkley J, Santanam N, Weintraub W, Parthasarathy S. Physical inactivity and cardiovascular risk: baseline observations from men and premenopausal women. J Clin Lab Anal. 2010; 24(2):100-5.
Score: 0.017
-
Garelnabi MO, Brown WV, Le NA. Evaluation of a novel colorimetric assay for free oxygen radicals as marker of oxidative stress. Clin Biochem. 2008 Oct; 41(14-15):1250-4.
Score: 0.016
-
Parthasarathy S, Litvinov D, Selvarajan K, Garelnabi M. Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability. Biochim Biophys Acta. 2008 May; 1781(5):221-31.
Score: 0.015
-
Guan Y, Ebrahimzadeh SA, Cheng CH, Chen W, Leung T, Bigornia S, Palacios N, Garelnabi MO, Scott T, Bhadelia R, Tucker KL, Koo BB. Association of Diabetes and Hypertension With Brain Structural Integrity and Cognition in the Boston Puerto Rican Health Study Cohort. Neurology. 2022 04 12; 98(15):e1534-e1544.
Score: 0.010
-
Grech J, Chan MV, Ochin C, Lachapelle A, Thibord F, Schneider Z, Nkambule BB, Armstrong PCJ, de Melendez CW, Tucker KL, Garelnabi M, Warner TD, Chen MH, Johnson AD. Serotonin-Affecting Antidepressant Use in Relation to Platelet Reactivity. Clin Pharmacol Ther. 2022 04; 111(4):909-918.
Score: 0.010
-
Parthasarathy S, Raghavamenon A, Garelnabi MO, Santanam N. Oxidized low-density lipoprotein. Methods Mol Biol. 2010; 610:403-17.
Score: 0.004
-
Raghavamenon A, Garelnabi M, Babu S, Aldrich A, Litvinov D, Parthasarathy S. Alpha-tocopherol is ineffective in preventing the decomposition of preformed lipid peroxides and may promote the accumulation of toxic aldehydes: a potential explanation for the failure of antioxidants to affect human atherosclerosis. Antioxid Redox Signal. 2009 Jun; 11(6):1237-48.
Score: 0.004
-
Jaichander P, Selvarajan K, Garelnabi M, Parthasarathy S. Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin. J Lipid Res. 2008 Oct; 49(10):2142-8.
Score: 0.004